The Scientist

» fMRI, disease/medicine and microbiology

Most Recent

image: Designing In Vitro Models of the Blood-Brain Barrier

Designing In Vitro Models of the Blood-Brain Barrier

By | September 1, 2016

Choosing the right model, be it 3-D or 2-D, requires wading through varied cell sources, cell types, and cell culture conditions.

0 Comments

image: Promoting Protein Partnerships

Promoting Protein Partnerships

By | September 1, 2016

Scientists generate new protein-protein interactions at an impressive PACE.

0 Comments

image: The Challenges of Rare-Disease Research

The Challenges of Rare-Disease Research

By | September 1, 2016

With few resources and hesitant investors, basic scientists must rely on clinicians, patient advocates, and their own keen eye for biological connections.

0 Comments

image: Protein or Perish

Protein or Perish

By | September 1, 2016

A bacteriophage must evolve certain variants of a protein or die.

0 Comments

image: Dogs Respond to Words and Inflection

Dogs Respond to Words and Inflection

By | August 31, 2016

Using an MRI scanner to examine how dogs’ brains process speech, researchers find that our canine companions hear both what we say and how we say it. 

0 Comments

image: One Receptor, Two Ligands, Different Responses

One Receptor, Two Ligands, Different Responses

By | August 31, 2016

Host and bacterial ligands that interact with the same cell-surface receptor induce different activities in human macrophages. 

0 Comments

image: One Antigen Receptor Induces Two T cell Types

One Antigen Receptor Induces Two T cell Types

By | August 26, 2016

Precursor T cells bearing the same antigen receptor adopt two different fates in mice.

1 Comment

image: Polio Reemerges in Nigeria

Polio Reemerges in Nigeria

By | August 15, 2016

Prior to last week’s announcement of newly confirmed cases, the country had been polio-free for two years.

1 Comment

image: Antibiotic Resistance Reaches Brazil

Antibiotic Resistance Reaches Brazil

By | August 8, 2016

Scientists detect a colistin-resistance gene in a clinical sample.

0 Comments

image: Fecal Transplant Pill Fails Trial

Fecal Transplant Pill Fails Trial

By | August 1, 2016

Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.

2 Comments

Popular Now

  1. Caloric Restriction Turns White Fat Brown
  2. New Lyme Disease Test Developed by Summer Student
  3. How to Build Bioinformatic Pipelines Using Galaxy
  4. One Antigen Receptor Induces Two T cell Types
script language="javascript" type="text/javascript"> $(document).ready( function() { $('a#internalDogEar').hover( function() { $(this).children('img').attr('src','https://www.labx.com/web/banners/originals/OriGene-Lenti_DogEar-500x500_Sept1-16.png'); }, function() { $(this).children('img').attr('src','https://www.labx.com/web/banners/originals/OriGene-Lenti_DogEar-100x100_SEPT1-16flt.gif'); } ); }); Lenti Particles and Vectors from OriGene